You need to upgrade your Flash Player

BAXTER INTL INC (BAX) 54.33 red arrow -$0.62 (-1.13%) 08:10PM (15 mins delay)


 October 18, 2009 - 10:00 PM EDT
Print Email Article Font Down Font Up Charts
Research and Markets: In-Depth Information and Data on Taiwan Drug Delivery Devices, Including Investment Opportunities, Analysis and Forecasts to 2015
Research and Markets: In-Depth Information and Data on Taiwan Drug Delivery Devices, Including Investment Opportunities, Analysis and Forecasts to 2015

Oct. 18, 2009 (Business Wire) -- Research and Markets (http://www.researchandmarkets.com/research/10aeaf/taiwan_drug_delive) has announced the addition of Global Markets Direct's new report "Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015" to their offering.

This report is an essential source for in-depth information and data relating to Taiwan drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Taiwan.

Scope:

  • The report provides information on the drug delivery devices market in Taiwan.
  • Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors such as Terumo Corporation, Baxter International Inc., JMS CO., LTD., Fresenius Kabi AG, and B. Braun Melsungen AG.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the drug delivery devices market in Taiwan.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Definitions of Markets Covered in This Report

4 Healthcare Sector Review

5 Regulation System

6 Pricing and Reimbursement

7 Distribution Structure

8 Drug Delivery Devices In Taiwan

9 Infusion Systems In Taiwan

10 Inhalation Systems In Taiwan

11 Overview of Key Companies in Taiwan Drug Delivery Devices Market

12 Financial Deals Landscape

13 Appendix

Companies Mentioned:

  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Baxter International Inc.
  • Novartis AG
  • Terumo Corporation
  • Cardinal Health, Inc.
  • GlaxoSmithKline plc
  • B. Braun Melsungen AG
  • Smiths Medical
  • Fresenius Kabi AG
  • Consort Medical plc
  • Hospira, Inc.

For more information visit http://www.researchandmarkets.com/research/10aeaf/taiwan_drug_delive


Source: Business Wire (October 18, 2009 - 10:00 PM EDT)

News by QuoteMedia
www.quotemedia.com



Make a suggestion for this page

Investing Channel Logo

Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.